Sio Gene Therapies Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q2 2017 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Sio Gene Therapies Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2017 to Q2 2022.
  • Sio Gene Therapies Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2022 was -$277K, a 107% decline year-over-year.
  • Sio Gene Therapies Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $3.65M, a 70.5% decline from 2020.
  • Sio Gene Therapies Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $12.4M.
  • Sio Gene Therapies Inc. annual Net Cash Provided by (Used in) Investing Activities for 2019 was -$255K, a 26.2% decline from 2018.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 -$277K -$4.44M -107% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q2 2021 $4.16M +$4.18M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q2 2020 -$19K +$59K +75.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q2 2019 -$78K -$78K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q2 2018 $0 +$2.17M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q2 2017 -$2.17M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.